The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,810.00
Bid: 1,807.50
Ask: 1,808.50
Change: 10.50 (0.58%)
Spread: 1.00 (0.055%)
Open: 1,797.00
High: 1,810.00
Low: 1,792.00
Prev. Close: 1,799.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Investors turn cautious ahead of FOMC minutes

Wed, 20th Nov 2013 08:19

- Bernanke comments in focus ahead of FOMC minutes- Telecom Plus buys back businesses from Npower- Diageo CEO warns of 'uncertain' global economytechMARK 2,637.85 -0.24%FTSE 100 6,687.39 -0.16%FTSE 250 15,243.72 -0.14%UK stocks declined on Wednesday as investors adopted a cautious approach ahead of the release of the minutes from the latest Federal Reserve policy meeting this evening.The Federal Open Market Committee (FOMC) will release details of its October meeting this afternoon as markets wait to hear about the central bank's decision to maintain its stimulus programme last month.However, comments from Fed Chairman Ben Bernanke last night were in focus this morning after he reiterated that any tapering of asset purchases remains dependent on incoming economic data, as he held back from shedding any light on the timetable for an impending withdrawal."This comes before the FOMC meetings minutes will be released later today which will undoubtedly lead to volatility as investors attempt to decipher the underlying sentiment of the FOMC," said Alex Conroy, Financial Sales Trader at Spreadex.Retail sales, consumer price inflation and existing-home sales data is also due out today from the US this afternoon. Meanwhile, investors closer to home will be watching closely for the release of the minutes from the Bank of England's latest policy meeting.Telecom Plus soars after H1 results, acquisitionsUtilities reseller Telecom Plus was a high riser this morning after agreeing to pay £218m to buy back two gas and electricity supply businesses from Npower which it sold in 2006. The announcement came as the firm delivered a 17% increase in revenues in the first half, as profits rose 10.1%.Drinks group Diageo was under the weather after Chief Executive Ivan Menezes was reported as saying that the "uncertain" macro environment will continue to limit sales growth. Sector peer SABMiller was also out of favour this morning.Airline group easyJet was extending gains made yesterday after the company delivered a 51% increase in annual profits and unveiled an unexpected special dividend to shareholders.GlaxoSmithKline rose after completing the partial sale of Aspen Pharmacare, raising gross proceeds of 7.06bn South African rand ($695m).Engineering and construction firm Kentz was higher after being awarded a $190m contract with Qatar Petroleum for services on 775 wells across the Dukhan Oilfield in Qatar, extending the firms' long-standing relationship which started back in 1997.FTSE 100 - RisersAberdeen Asset Management (ADN) 487.80p +2.65%easyJet (EZJ) 1,367.00p +1.64%Pearson (PSON) 1,348.00p +1.43%London Stock Exchange Group (LSE) 1,593.00p +1.34%British Sky Broadcasting Group (BSY) 835.00p +1.21%Travis Perkins (TPK) 1,743.00p +1.04%William Hill (WMH) 364.80p +0.97%Royal Bank of Scotland Group (RBS) 330.70p +0.95%Shire Plc (SHP) 2,824.00p +0.86%Persimmon (PSN) 1,193.00p +0.68%FTSE 100 - FallersRexam (REX) 494.50p -1.79%Vodafone Group (VOD) 228.05p -1.72%Diageo (DGE) 1,999.50p -1.43%Weir Group (WEIR) 2,185.00p -1.27%Tate & Lyle (TATE) 811.00p -1.22%Hammerson (HMSO) 509.00p -1.17%Centrica (CNA) 338.10p -1.14%Intertek Group (ITRK) 3,067.00p -1.13%Sainsbury (J) (SBRY) 407.50p -1.02%Meggitt (MGGT) 501.50p -0.99%FTSE 250 - RisersTelecom Plus (TEP) 1,711.00p +13.54%Perform Group (PER) 443.80p +3.21%International Personal Finance (IPF) 591.50p +2.69%Kentz Corporation Ltd. (KENZ) 556.00p +2.58%BH Global Ltd. USD Shares (BHGU) 11.91 +1.79%Barratt Developments (BDEV) 326.80p +1.78%Telecity Group (TCY) 683.00p +1.64%Lancashire Holdings Limited (LRE) 804.00p +1.45%Devro (DVO) 310.90p +1.44%KCOM Group (KCOM) 104.40p +1.36%FTSE 250 - FallersHenderson Group (HGG) 216.90p -1.86%Centamin (DI) (CEY) 48.98p -1.84%Spirent Communications (SPT) 103.90p -1.70%Dunelm Group (DNLM) 879.00p -1.68%Bodycote (BOY) 608.50p -1.62%African Barrick Gold (ABG) 188.60p -1.62%Hikma Pharmaceuticals (HIK) 1,194.00p -1.57%Great Portland Estates (GPOR) 562.00p -1.40%Witan Inv Trust (WTAN) 650.50p -1.36%Afren (AFR) 158.90p -1.30%BC
More News
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.